专题：Drug-Induced Adverse Reactions

This cluster of papers focuses on hypersensitivity reactions to various drugs and medications, including the role of specific HLA genotypes such as HLA-B*5701, HLA-B*1502, and HLA-B*5801 in predicting severe cutaneous adverse reactions like Stevens-Johnson Syndrome and Toxic Epidermal Necrolysis. The cluster also covers topics related to drug-induced hypersensitivity syndrome (DIHS), delayed drug hypersensitivity reactions, and the use of genetic screening to prevent abacavir hypersensitivity reactions.
最新文献
Breaking barriers: A communication bundle for penicillin allergy label removal

article Full Text OpenAlex

Comprehensive Clinical and Pharmacological Study of Antiallergic Drugs in Patients with Infectious Respiratory Diseases: SWOT-, PESTEL-, Content Analysis

article Full Text OpenAlex

Real-world safety assessment of burosumab: a pharmacovigilance study utilizing the FDA adverse event reporting system

article Full Text OpenAlex

Analysis of adverse event reporting with casimersen: a pharmacovigilance study based on the United States food and drug administration adverse event reporting system database

article Full Text OpenAlex

Toxic epidermal necrolysis induced by lamotrigine with suspected venlafaxine-related relapse

article Full Text OpenAlex

Feasibility Trial of Prolonged versus Single-Dose Challenge in Penicillin Allergy

article Full Text OpenAlex

Comparative disproportionality signals for methotrexate monotherapy versus methotrexate combined with hydroxychloroquine, leflunomide, or sulfasalazine in rheumatoid arthritis: newly highlighted signals evaluated using drug information safety profiles

article Full Text OpenAlex

Stevens-Johnson syndrome/toxic epidermal necrolysis induced by sintilimab in a patient with advanced non-small cell lung cancer: A case report

article Full Text OpenAlex

A pharmacovigilance analysis of carbapenem-related utilizing the FDA adverse event reporting system (FAERS) database from 2013 to 2025

article Full Text OpenAlex

Duodenal Small Bowel Diaphragm Disease: A Rare and Underrecognized Complication of Chronic NSAID Use

article Full Text OpenAlex

近5年高被引文献
Management of toxicities from immunotherapy: ESMO Clinical Practice Guideline for diagnosis, treatment and follow-up

article Full Text OpenAlex 1008 FWCI95.1173

Annals of the Rheumatic Diseases

paratext Full Text OpenAlex 712 FWCI0

A 12-gene pharmacogenetic panel to prevent adverse drug reactions: an open-label, multicentre, controlled, cluster-randomised crossover implementation study

article Full Text OpenAlex 468 FWCI119.1311

Drug allergy: A 2022 practice parameter update

article Full Text OpenAlex 445 FWCI71.4936

Polyethylene glycol (PEG): The nature, immunogenicity, and role in the hypersensitivity of PEGylated products

review Full Text OpenAlex 391 FWCI63.0109

Chlorhexidine in Dentistry: Pharmacology, Uses, and Adverse Effects

review Full Text OpenAlex 324 FWCI44.6932

Anaphylaxis: A 2023 practice parameter update

article Full Text OpenAlex 247 FWCI60.3893

The REporting of A Disproportionality Analysis for DrUg Safety Signal Detection Using Individual Case Safety Reports in PharmacoVigilance (READUS-PV): Explanation and Elaboration

article Full Text OpenAlex 224 FWCI81.3435

Worldwide emergence of fluconazole-resistant Candida parapsilosis: current framework and future research roadmap

review Full Text OpenAlex 210 FWCI40.9696

Global antibiotic use during the COVID-19 pandemic: analysis of pharmaceutical sales data from 71 countries, 2020–2022

article Full Text OpenAlex 205 FWCI37.9608